Fenfluramine: New Treatment for Seizures in Dravet Syndrome

Investigators for the FAiRE DS Study Group assessed the efficacy and safety of Fenfluramine for treating seizures in patients less than 18 y.o. with Dravet Syndrome in an international double-blind, placebo-controlled clinical trial. A total of 119 patients (mean age 9.0 y, 54% male) were enrolled i...

Descripción completa

Detalles Bibliográficos
Autores principales: Pierce, Joanna Garcia, Mithal, Divakar S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pediatric Neurology Briefs Publishers 2020
Materias:
Epileptic Encephalopathies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071945/
https://www.ncbi.nlm.nih.gov/pubmed/32189958
http://dx.doi.org/10.15844/pedneurbriefs-34-8
_version_ 1783506306051604480
author Pierce, Joanna Garcia
Mithal, Divakar S.
author_facet Pierce, Joanna Garcia
Mithal, Divakar S.
author_sort Pierce, Joanna Garcia
collection PubMed
description Investigators for the FAiRE DS Study Group assessed the efficacy and safety of Fenfluramine for treating seizures in patients less than 18 y.o. with Dravet Syndrome in an international double-blind, placebo-controlled clinical trial. A total of 119 patients (mean age 9.0 y, 54% male) were enrolled in the study.
format Online
Article
Text
id pubmed-7071945
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Pediatric Neurology Briefs Publishers
record_format MEDLINE/PubMed
spelling pubmed-70719452020-03-18 Fenfluramine: New Treatment for Seizures in Dravet Syndrome Pierce, Joanna Garcia Mithal, Divakar S. Pediatr Neurol Briefs Epileptic Encephalopathies Investigators for the FAiRE DS Study Group assessed the efficacy and safety of Fenfluramine for treating seizures in patients less than 18 y.o. with Dravet Syndrome in an international double-blind, placebo-controlled clinical trial. A total of 119 patients (mean age 9.0 y, 54% male) were enrolled in the study. Pediatric Neurology Briefs Publishers 2020-03-12 /pmc/articles/PMC7071945/ /pubmed/32189958 http://dx.doi.org/10.15844/pedneurbriefs-34-8 Text en Copyright: © 2020 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under the Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Epileptic Encephalopathies
Pierce, Joanna Garcia
Mithal, Divakar S.
Fenfluramine: New Treatment for Seizures in Dravet Syndrome
title Fenfluramine: New Treatment for Seizures in Dravet Syndrome
title_full Fenfluramine: New Treatment for Seizures in Dravet Syndrome
title_fullStr Fenfluramine: New Treatment for Seizures in Dravet Syndrome
title_full_unstemmed Fenfluramine: New Treatment for Seizures in Dravet Syndrome
title_short Fenfluramine: New Treatment for Seizures in Dravet Syndrome
title_sort fenfluramine: new treatment for seizures in dravet syndrome
topic Epileptic Encephalopathies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071945/
https://www.ncbi.nlm.nih.gov/pubmed/32189958
http://dx.doi.org/10.15844/pedneurbriefs-34-8
work_keys_str_mv AT piercejoannagarcia fenfluraminenewtreatmentforseizuresindravetsyndrome
AT mithaldivakars fenfluraminenewtreatmentforseizuresindravetsyndrome

Ejemplares similares